Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

María Domercq

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Trends in Pharmacological Sciences|November 9, 2004
Neuroprotection by tetracyclinesMaría Domercq, Carlos Matute
Current Opinion in Pharmacology|April 25, 2019
Targeting P2X4 and P2X7 receptors in multiple sclerosisMaría Domercq, C Matute
Therapeutic Advances in Neurological Disorders|May 19, 2018
Inflammation in stroke: the role of cholinergic, purinergic and glutamatergic signalingAbraham Martín, María Domercq, Carlos Matute
Journal of Neurochemistry|July 27, 2005
A novel alternative splicing form of excitatory amino acid transporter 1 is a negative regulator of glutamate uptakeAinara Vallejo-Illarramendi, María Domercq, Carlos Matute
Frontiers in Cellular Neuroscience|April 30, 2013
Neurotransmitter signaling in the pathophysiology of microgliaMaría Domercq, Nuria Vázquez-Villoldo, Carlos Matute
Frontiers in Cellular Neuroscience|March 3, 2020
Functional and Metabolic Characterization of Microglia Culture in a Defined MediumAlejandro Montilla, Alazne Zabala, Carlos Matute, et al.
Glia|October 6, 2005
Glutamate-mediated glial injury: mechanisms and clinical importanceCarlos Matute, María Domercq, María-Victoria Sánchez-Gómez
Glia|May 14, 2005
Excitotoxic oligodendrocyte death and axonal damage induced by glutamate transporter inhibitionMaría Domercq, Estibaliz Etxebarria, Alberto Pérez-Samartín, et al.
Stroke|December 6, 2012
Protecting white matter from stroke injuryCarlos Matute, María Domercq, Alberto Pérez-Samartín, et al.
Neurobiology of Disease|August 3, 2005
Increased expression and function of glutamate transporters in multiple sclerosisAinara Vallejo-Illarramendi, María Domercq, Fernando Pérez-Cerdá, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Trends in Pharmacological Sciences|November 9, 2004
Neuroprotection by tetracyclinesMaría Domercq, Carlos Matute
Current Opinion in Pharmacology|April 25, 2019
Targeting P2X4 and P2X7 receptors in multiple sclerosisMaría Domercq, C Matute
Therapeutic Advances in Neurological Disorders|May 19, 2018
Inflammation in stroke: the role of cholinergic, purinergic and glutamatergic signalingAbraham Martín, María Domercq, Carlos Matute
Journal of Neurochemistry|July 27, 2005
A novel alternative splicing form of excitatory amino acid transporter 1 is a negative regulator of glutamate uptakeAinara Vallejo-Illarramendi, María Domercq, Carlos Matute
Frontiers in Cellular Neuroscience|April 30, 2013
Neurotransmitter signaling in the pathophysiology of microgliaMaría Domercq, Nuria Vázquez-Villoldo, Carlos Matute
Frontiers in Cellular Neuroscience|March 3, 2020
Functional and Metabolic Characterization of Microglia Culture in a Defined MediumAlejandro Montilla, Alazne Zabala, Carlos Matute, et al.
Glia|October 6, 2005
Glutamate-mediated glial injury: mechanisms and clinical importanceCarlos Matute, María Domercq, María-Victoria Sánchez-Gómez
Glia|May 14, 2005
Excitotoxic oligodendrocyte death and axonal damage induced by glutamate transporter inhibitionMaría Domercq, Estibaliz Etxebarria, Alberto Pérez-Samartín, et al.
Stroke|December 6, 2012
Protecting white matter from stroke injuryCarlos Matute, María Domercq, Alberto Pérez-Samartín, et al.
Neurobiology of Disease|August 3, 2005
Increased expression and function of glutamate transporters in multiple sclerosisAinara Vallejo-Illarramendi, María Domercq, Fernando Pérez-Cerdá, et al.
Pageof 4